Experiencing trauma can sometimes lead to post-traumatic stress disorder (PTSD). This serious mental health condition is marked by changes in mood, intrusive memories, avoidant behavior, and a ...

In Part 1 of my interview with trauma expert Brad Kammer, LMFT, currently on the faculty of the NARM Training Institute, we discussed how Brad and his colleagues distinguish between PTSD and complex ...

A new digital resource co-created by University of Victoria (UVic) researchers and trauma survivors will streamline access to resources and tools for clinicians who support people with complex ...

This National Eating Disorder Awareness Week, The Dorm--a leader in young adult mental health treatment--will co-host a continuing education event with NEDA that spotlights an often-overlooked ...

According to the AEON Medical Team, EXOMIND™ is a recalibration of the human experience rather than only a medication. "By focusing on the particular neural circuits engaged in focus, anxiety, and ...

An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12-week, phase IIb study. In a modified intent-to-treat analysis of 182 ...

KIRKLAND, Wash. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Freespira, Inc., developer of the only FDA-cleared at-home treatment for panic disorder, anxiety attacks, and post-traumatic stress disorder (PTSD) ...

Veteran - please stop suffering and get the help you deserve. Semi-Private Studios and Private Treatment Offices for Maximum Comfort and Healing. Premier Veterans-only Psychiatric Treatment Program ...

The use of MDMA as a treatment for post-traumatic stress disorder (PTSD) has been rejected by a U.S. Food and Drug Administration (FDA) committee following recent trials. The decision was made at an ...

The U.S. Food and Drug Administration (FDA) announced Friday its rejection of MDMA as a treatment for PTSD. The decision was based on "significant limitations" that "prevent the agency from concluding ...